-
Top News: Proteon Therapeutics Inc (NASDAQ:PRTO), MakeMyTrip Limited (NASDAQ:MMYT), Rubicon Technology (NASDAQ:RBCN), Astronics Corporation (NASDAQ:ATRO), Authentidate Holding Corp. (NASDAQ:ADAT)
On Friday shares of Proteon Therapeutics Inc (NASDAQ:PRTO) closed at $16.49. Net loss for the first quarter of 2015 was $4.6 million as compared to $2.8 million for the first quarter of 2014. On 13 May, Proteon Therapeutics Inc (NASDAQ:PRTO) reported Net loss includes stock-based compensation expense of $0.4 million for the first quarter of…
-
Morning Buzz: INSYS Therapeutics (NASDAQ:INSY), Proteon Therapeutics Inc (NASDAQ:PRTO), Aerohive Networks (NYSE:HIVE), Innovative Solutions & Support Inc. (NASDAQ:ISSC)
On Tuesday shares of INSYS Therapeutics, Inc. (NASDAQ:INSY) closed at $53.50. Company’s EPS growth for next 5 years is recorded as 28.00%. INSYS Therapeutics, Inc. (NASDAQ:INSY) announced that the Company will release its financial results for the first quarter 2015 on Thursday, May 7, 2015, before the U.S. financial markets open. Proteon Therapeutics Inc (NASDAQ:PRTO)…
-
Stocks in Focus: Tekmira Pharmaceuticals Corp (NASDAQ:TKMR), Proteon Therapeutics Inc (NASDAQ:PRTO), AbbVie Inc. (NYSE:ABBV), Peabody Energy Corp. (NYSE:BTU), Acura Pharmaceuticals (NASDAQ:ACUR)
On Friday shares of Tekmira Pharmaceuticals Corp (NASDAQ:TKMR) closed at $18.19. Company’s sales growth for last 5 years was 5.80%. On 10 April, Tekmira Pharmaceuticals Corp (NASDAQ:TKMR) said that the U.S. Food and Drug Administration has cleared it to continue clinical trials of its Ebola treatment. Proteon Therapeutics Inc (NASDAQ:PRTO) in last trading activity moved…
-
Hot Stocks: Sirius XM Holdings Inc. (NASDAQ:SIRI), Proteon Therapeutics Inc (NASDAQ:PRTO), Continental Resources (NYSE:CLR), Potash Corp. (NYSE:POT), Clean Harbors (NYSE:CLH)
Sirius XM Holdings Inc. (NASDAQ:SIRI) on Wednesday closed at $3.90. Stock institutional ownership is 23.50% while insider ownership includes 57.91%. Sirius XM Holdings Inc. (NASDAQ:SIRI) distance from 50-day simple moving average (SMA50) is 1.63%. On 7 April, Sirius XM Holdings Inc. (NASDAQ:SIRI) said that, it will live broadcast some of the performances from the Coachella…
-
Momentum Stocks: Proteon Therapeutics Inc (NASDAQ:PRTO), The AES Corporation (NYSE:AES), Oracle Corporation (NYSE:ORCL), Emergent BioSolutions (NYSE:EBS), Cisco Systems (NASDAQ:CSCO)
On Monday shares of Proteon Therapeutics Inc (NASDAQ:PRTO) closed at $12.45.On 2 April, Proteon Therapeutics Inc (NASDAQ:PRTO) announced positive results from a long-term analysis of more than three years of follow-up data from a Phase 2 study of its drug vonapanitase (formerly PRT-201). The AES Corporation (NYSE:AES) in last trading activity increased 3.82% to close…
-
5 Stocks in Dramatic Moves: Southwest Airlines Co. (NYSE:LUV), Proteon Therapeutics Inc (NASDAQ:PRTO), Lincoln National (NYSE:LNC), Westell Technologies (NASDAQ:WSTL), Hanmi Financial (NASDAQ:HAFC)
Southwest Airlines Co. (NYSE:LUV) announced it will share $355 million through its ProfitSharing Plan with its Employees for 2014—equaling approximately 9.6 percent of each eligible Employee’s eligible compensation, or the equivalent of five weeks’ pay. This $355 million contribution—nearly $1 million a day—is the largest total dollar amount Southwest has ever allocated to ProfitSharing. On…
-
Market Watch List: Gilead Sciences Inc. (NASDAQ:GILD), Proteon Therapeutics Inc (NASDAQ:PRTO), Basic Energy Services (NYSE:BAS), Sohu.com Inc. (NASDAQ:SOHU), Apple Inc. (NASDAQ:AAPL)
On 7 January Gilead Sciences Inc. (NASDAQ:GILD) said that it has started 2015 off with a bang; the company is now looking to shoulder its way into the nonalcoholic steatohepatitis (NASH) market by announcing to buy out closely held Phenex Pharmaceuticals AG’s liver-disease program. On Friday shares of Gilead Sciences Inc. (NASDAQ:GILD) closed at $102.21.…
-
Whats Hot Today: Proteon Therapeutics (NASDAQ:PRTO), Halliburton Company (NYSE:HAL), Lime Energy Co. (NASDAQ:LIME), CoStar Group Inc. (NASDAQ:CSGP), Beasley Broadcast Group (NASDAQ:BBGI)
Proteon Therapeutics (NASDAQ:PRTO) Insider James E. Flynn bought 691,713 shares of the company’s stock in a transaction dated Monday, October 27th. The shares were purchased at an average price of $10.00 per share, for a total transaction of $6,917,130.00. Proteon Therapeutics, Inc. (NASDAQ:PRTO) in last trading activity moved down -0.40% to close at $10.00. Company…